GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Genesco Inc (NYSE:GCO) » Definitions » EBIT

Genesco (Genesco) EBIT : $-14 Mil (TTM As of Jan. 2024)


View and export this data going back to 1939. Start your Free Trial

What is Genesco EBIT?

Genesco's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2024 was $37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was $-14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Genesco's annualized ROC % for the quarter that ended in Jan. 2024 was 7.52%. Genesco's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 14.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Genesco's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -1.77%.


Genesco EBIT Historical Data

The historical data trend for Genesco's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesco EBIT Chart

Genesco Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.71 -106.58 155.44 92.99 -14.00

Genesco Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.79 -23.09 -38.78 10.70 37.16

Competitive Comparison of Genesco's EBIT

For the Apparel Retail subindustry, Genesco's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesco's EV-to-EBIT Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Genesco's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Genesco's EV-to-EBIT falls into.



Genesco EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesco  (NYSE:GCO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Genesco's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=154.072 * ( 1 - 43.05% )/( (1208.926 + 1124.842)/ 2 )
=87.744004/1166.884
=7.52 %

where

Invested Capital(Q: Oct. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1492.931 - 262.314 - ( 21.691 - max(0, 397.164 - 638.71+21.691))
=1208.926

Invested Capital(Q: Jan. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1329.89 - 169.893 - ( 35.155 - max(0, 319.537 - 507.351+35.155))
=1124.842

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Genesco's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=148.652/( ( (704.533 + max(354.705, 0)) + (677.162 + max(281.848, 0)) )/ 2 )
=148.652/( ( 1059.238 + 959.01 )/ 2 )
=148.652/1009.124
=14.73 %

where Working Capital is:

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(56.934 + 516.735 + 43.35) - (262.314 + 0 + 0)
=354.705

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(53.618 + 378.967 + 39.611) - (169.893 + 0 + 20.455)
=281.848

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Genesco's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2024 )
=-13.997/789.283
=-1.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesco EBIT Related Terms

Thank you for viewing the detailed overview of Genesco's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesco (Genesco) Business Description

Traded in Other Exchanges
Address
535 Marriott Drive, Nashville, TN, USA, 37214
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and catalog and wholesale distribution of products under the Johnston & Murphy and H.S. Trask brands. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
Executives
Gregory A Sandfort director GENESCO INC., 535 MARRIOTT DRIVE, NASHVILLE TN 37214
Matthew C Diamond director
Daniel E Ewoldsen officer: Senior VP 535 MARRIOTT DRIVE, NASHVILLE TN 37214
Mimi Eckel Vaughn officer: Vice President C/O GENESCO INC, 535 MARRIOTT DRIVE, NASHVILLE TN 37214
Thomas George officer: Sr VP-Finance and Interim CFO 535 MARRIOTT DRIVE, NASHVILLE TN 37214
Matthew M Bilunas director C/O BEST BUY CO., INC., 7601 PENN AVENUE SOUTH, RICHFIELD MN 55423
Carolyn Bojanowski director 79 CLYDE, SAN RAFAEL CA 94901
Kathleen Mason director GENESCO INC., 1415 MURFREESBORO ROAD, NASHVILLE TN 37217
Mary E Meixelsperger director 810 DSW DRIVE, COLUMBUS OH 43219
Angel R Martinez director C/O TUPPERWARE BRANDS CORP, PO BOX 2353, ORLANDO FL 32802-2353
Marty G Dickens director
Thurgood Jr Marshall director 3000 K STREET N W, SUITE 300, WASHINGTON DC 20007-5116
John F Lambros director 535 MARRIOTT DRIVE, NASHVILLE TN 37214
Robert J Dennis officer: Senior Vice President GENESCO INC., 1415 MURFREESBORO ROAD, NASHVILLE TN 37217
Brently G. Baxter officer: VP & Chief Accounting Officer C/O GENESCO INC., 535 MARRIOTT DRIVE, NASHVILLE TN 37214